Skip to main content
Clinical Trials/NL-OMON52658
NL-OMON52658
Completed
Phase 4

A cluster Randomised Controlled Trial of the effectiveness, usability and acceptability of a smart inhaler programme in asthma patients: the ACCEPTANCE study - ACCEPTANCE study

eids Universitair Medisch Centrum0 sites242 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
eids Universitair Medisch Centrum
Enrollment
242
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \>\= 18 years;
  • Doctor\-diagnosed asthma (according to Dutch national primary care asthma
  • guidelines (NHG)) \- route A and B; Self\-reported asthma diagnosis (confirmed at
  • study end (T12\) by GP) \- route C;
  • Partially controlled or uncontrolled asthma (ACQ \>\= 0\.75\);
  • Use of Symbicort Turbuhaler maintenance therapy;
  • Being 'non\-adherent' defined as an adherence rate (number of fully adherent
  • days / total number of days) of below 80% over the 3rd and 4th week of the
  • run\-in period.

Exclusion Criteria

  • Use of SMART regimen (Symbicort Maintenance And Reliever Therapy) by taking
  • Symbicort as reliever in response to symptoms;
  • Change in inhaled corticosteroids dose in the 4 weeks prior to run\-in period;
  • Use of systemic corticosteroids in the 4 weeks prior to run\-in period;
  • Current use of biologics, (anti\-IL\-5 en anti\-IgE);
  • Diagnosis of COPD or other significant respiratory diseases;
  • Malignancy with life expectancy \< 1 year;
  • Inability to understand Dutch.

Outcomes

Primary Outcomes

Not specified

Similar Trials